Among sell-side analysts on Wall Street, Morgan Stanley is one of the most well-known. The company’s large investment banking ...

We recently compiled a list of the 10 AI Stocks to Watch Amid the DeepSeek Buzz. In this article, we are going to take a look ...

Financial giants have made a conspicuous bullish move on Morgan Stanley. Our analysis of options history for Morgan Stanley (NYSE:MS) revealed 8 unusual trades. Delving into the details ...

Morgan Stanley (MS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Whales with a lot of money to spend have taken a noticeably bearish stance on Morgan Stanley. Looking at options history for Morgan Stanley (NYSE:MS) we detected 24 trades. If we consider the ...

Multinational investment bank and financial services giant Morgan Stanley (NYSE:MS) delivered an impressive performance in its fourth quarter of 2024. As reported on Thursday, Jan. 16, the firm's ...

Morgan Stanley (MS) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $1.65 per share. This compares to earnings of $1.13 per share a year ago.

Morgan Stanley has downgraded Intellia Therapeutics (NASDAQ:NTLA) to equal weight from overweight citing "a more measured launch" of its transthyretin amyloidosis (ATTR) candidate nexiguran ziclumeran ...

Exelixis (NASDAQ:EXEL) shares, with a market capitalization of $9.2 billion, received an optimistic update from Morgan Stanley (NYSE:MS), as the firm's analyst Sean Laaman upgraded the ...

Morgan Stanley (NYSE:MS) reaffirmed its Overweight rating on Sarepta Therapeutics (NASDAQ:SRPT), an $11.27 billion market cap biotechnology company, with a steady price target of $200.00. The ...

Nvidia shares closed down almost 17%, posting its biggest drop since March 2020 and erasing nearly $600 billion from the ...

Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at D. Boral ...